legislation: 102-hr-4896

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
102-hr-4896 102 hr 4896 To extend the patent term of certain products. Commerce 1992-04-09 1992-04-09 Referred to the House Committee on Judiciary. House Rep. Clay, William (Bill) [D-MO-1] MO D C000488 11 Amends Federal patent law to extend the patent term for certain drugs composed of non-steroidal anti-inflammatory agents if during the regulatory review process the patentee: (1) filed a new drug application in 1982; (2) awaited approval by the Food and Drug Administration for at least 78 months; and (3) such new drug application was approved in 1991. Prescribes a formula for patent term extension and sets forth administrative notification procedures. 2021-06-02T14:52:40Z  

Links from other tables